Literature DB >> 14441417

The role of psychotropic drugs in group therapy.

R A SANDISON.   

Abstract

The purpose of this paper is to examine those aspects of the drug treatment of mental disorder which relate to the human environment or group in which the patient finds himself. Although great claims are made for modern drug therapy, a distinction must be drawn between the specific effects of drugs and the effects of the environment itself. Psychotropic drugs are not specific in a particular disease, although they may modify specific symptoms. Two special cases are selected for an examination of the effects of the environment on drug action-deep insulin treatment and lysergic acid diethylamide. The psychological phenomena induced by deep insulin differ according to whether treatment is given individually or to a group of patients; and the psychological significance of insulin treatment lies in the ability of the treatment situation to help the patient to become a full member of the group. Similarly the group influences relating to LSD treatment are examined.It is concluded that the attitude of social groups to psychotropic drugs is determined by the real or apparent effects these drugs have on super-ego function. This appears to have some relationship to the so-called placebo phenomenon.The fact that clinical trials tend to lead to results unduly favourable to the drugs tested is noted and some suggestions are made as to how these trials can be improved.

Entities:  

Keywords:  PSYCHOTHERAPY, GROUP; TRANQUILIZING AGENTS/therapy

Mesh:

Substances:

Year:  1959        PMID: 14441417      PMCID: PMC2537975     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  9 in total

1.  Placebo response.

Authors:  A A BAKER; J G THORPE
Journal:  AMA Arch Neurol Psychiatry       Date:  1957-07

2.  Medicinal treatment: its aims and results.

Authors:  H H DALE
Journal:  Br Med J       Date:  1957-08-24

3.  Back to moral treatment and community care.

Authors:  T P REES
Journal:  J Ment Sci       Date:  1957-04

4.  [Psilocybin, a psychotropic substance from the Mexican mushroom Psilicybe mexicana Heim].

Authors:  A HOFMANN; R HEIM; A BRACK; H KOBEL
Journal:  Experientia       Date:  1958-03-15

5.  Clinical research in psychiatry.

Authors:  G A FOULDS
Journal:  J Ment Sci       Date:  1958-04

6.  Glucose and insulin in schizophrenia.

Authors:  S R LEYTON
Journal:  Lancet       Date:  1958-06-14       Impact factor: 79.321

7.  Psychopharmacotherapeutic research; a triadistic approach.

Authors:  H A RASHKIS; E R SMARR
Journal:  AMA Arch Neurol Psychiatry       Date:  1957-02

8.  Physiological treatment.

Authors:  J WORTIS
Journal:  Am J Psychiatry       Date:  1957-01       Impact factor: 18.112

9.  The psychology of insulin coma treatment.

Authors:  R D SCOTT
Journal:  Br J Med Psychol       Date:  1950
  9 in total
  3 in total

Review 1.  Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of the Literature.

Authors:  Tasha L Golden; Susan Magsamen; Clara C Sandu; Shuyang Lin; Grace Marie Roebuck; Kathy M Shi; Frederick S Barrett
Journal:  Curr Top Behav Neurosci       Date:  2022

2.  Traditional medicines and globalization: current and future perspectives in ethnopharmacology.

Authors:  Marco Leonti; Laura Casu
Journal:  Front Pharmacol       Date:  2013-07-25       Impact factor: 5.810

Review 3.  Current Perspective on the Therapeutic Preset for Substance-Assisted Psychotherapy.

Authors:  Sascha B Thal; Stephen J Bright; Jason M Sharbanee; Tobias Wenge; Petra M Skeffington
Journal:  Front Psychol       Date:  2021-07-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.